Multi-platform deep sequencing of SARS-CoV-2 JN.1 lineages variation reveal immune escape and transmission

Author:

Lang Xingying1,Wang Yue1,Luan Mingchun1,BO Zhijian1,Wang Huan1,Teng Xue1,Meng Xuehong2,Niu Shumin3,Cui Xiaoman1,Xia Nan3

Affiliation:

1. Dalian Center for Disease Control and Prevention

2. Thermo Fisher Scientific

3. The First Affiliated Hospital of China Medical University

Abstract

Abstract Objectives Dominant strains had been replaced by SARS-CoV-2 JN.1 lineages, and spread widely in a short period of time. However, accurate detection method and reason for rapid spread have not been clarified. Methods Ion Torrent, Illumina and Nanopore sequencing platforms were used to detect whole genome sequences of SARS-CoV-2 positive cases in Dalian CDC from December 2023 to January 2024. Results Ion Torrent and Illumina platform had missing sites, but optimized Ion Torrent and Nanopore platform covered all detected sites. Ion Torrent platform had higher sensitivity than others and was more suitable for short-read length sequencing. However, primers need to be optimized in time. Illumina platform was also suitable for short-read length and prone to site drop out. Nanopore platform was more suitable for long read-length sequencing and had high compatibility for more variation site. Furthermore, compared JN.1 lineages with BA.2.86, multiple specific variation sites were detected for the first time in non-S protein region. Conclusion Timely optimized primers and supplement variation sites will provide a more effective mean for monitoring and controlling the prevalence of JN.1 lineages in advance, and the discovery of specific variation sites may reveal the reasons for immune escape and rapid transmission.

Publisher

Research Square Platform LLC

Reference12 articles.

1. Update on SARS-CoV-2 variant JN.1 being tracked by CDC. Centers for Disease Control and Prevention. 2023. Accessed December 26, 2023. https://www.cdc.gov/respiratory-viruses/whats- new/SARS-CoV-2-variant-JN.1.html.

2. CDC continues to track the growth of JN.1. Centers for Disease Control and Prevention. 2023. Accessed December 26, 2023. https://www.cdc.gov/respiratory-viruses/whats-new/JN.1-update- 2023-12-22.html.

3. Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86;Yang S;Lancet Infect Dis,2023

4. Tracing the new SARS-CoV-2 variant BA.2.86 in the community through wastewater surveillance in Bangkok, Thailand;Wannigama DL;Lancet Infect Dis,2023

5. Antigenicity and receptor afffnity of SARS-CoV-2 BA.2.86 spike;Wang Q;Nature,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3